Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Telotristat

Telotristat

Telotristat structure

Telotristat 

structure
  • CAS No:

    1033805-28-5

  • Formula:

    C25H22ClF3N6O3

  • Chemical Name:

    Telotristat

  • Synonyms:

    LP778902; (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)-phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid; (S)-2-amino-3-[4-(2-amino-6-{(R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy}pyrimidine-4-yl)phenyl]propionic acid; (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoic acid; (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid;

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Telotristat is a phenylalanine derivative.|A tryptophan hydroxylase inhibitor. [Telotristat ethyl] (brand name Xermelo) is a prodrug of telotristat.|Telotristat is a Tryptophan Hydroxylase Inhibitor. The mechanism of action of telotristat is as a Tryptophan Hydroxylase Inhibitor.|Telotristat is an oral, small molecule inhibitor of tryptophan hydroxylase that is used in the treatment of symptoms of carcinoid syndrome. Telotristat is associated with modest rate of minor serum enzyme elevations during therapy but has not been linked to cases of clinically apparent liver injury.

Telotristat Basic Attributes

546.92900

546.1394008

381V4FCV2Z

DTXSID60145805

A - Alimentary tract and metabolism

Characteristics

142.17000

5.79160

1.50±0.1g/cm3

Sparingly Soluble (1.5E-3 g/L) (25 ºC), Calc.

Toxicity

In small clinical trials of telotristat in patients with neuroendocrine tumors and symptomatic diarrhea despite stable doses of somatostatin analogues, transient, asymptomatic and mild serum elevations of ALT occurred in 4% to 5% and of GGT in 6% to 9% of treated subjects. Apparent liver injury with jaundice was not observed in the several prelicensure clinical trials and has not been reported in the limited clinical experience with this agent since its approval.

Drug Information

Telotristat is an oral, small molecule inhibitor of tryptophan hydroxylase that is used in the treatment of symptoms of carcinoid syndrome. Telotristat is associated with modest rate of minor serum enzyme elevations during therapy but has not been linked to cases of clinically apparent liver injury.

Antineoplastic Agents

LX1032

Computed Properties

Molecular Weight:546.9
XLogP3:2.1
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:8
Exact Mass:546.1394008
Monoisotopic Mass:546.1394008
Topological Polar Surface Area:142
Heavy Atom Count:38
Complexity:790
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Telotristat

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.